Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Peripheral Neurostimulation

5 novembre 2026 mis à jour par: Jean-Louis Horn, Stanford University

Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.

Aperçu de l'étude

Description détaillée

The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.

By studying this subject, the investigators open possibilities for improvement on many levels:

increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.

The results of this study will open the door to novel approaches to manage acute post-operative pain.

Type d'étude

Interventionnel

Inscription (Estimé)

150

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • California
      • Stanford, California, États-Unis, 94305
        • Stanford University Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Undergoing elective upper limb surgery with a planned brachial plexus nerve block

Exclusion Criteria:

  • Under 18 years old
  • ASA score above III
  • Chronic pain condition with daily milligrams of morphine equivalent > 30
  • Poorly controlled psychiatric condition
  • Coagulopathy
  • Active infection
  • Moderate, severe or progressing neuropathy
  • COPD/Chronic oxygen user
  • Pregnancy
  • Incarceration
  • Unable to consent
  • BMI > 35
  • Pacemaker

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Ultrasound-guided brachial plexus block with peripheral nerve stimulation

Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch.

Nerve stimulator that is traditionally used for nerve localization during block placements.

Comparateur factice: Ultrasound-guided brachial plexus block without peripheral nerve stimulation

Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient.

Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Onset of Motor Block
Délai: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve)

Within 1 hour after the block placement.
Onset of Sensory Block
Délai: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder.

Within 1 hour after the block placement.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Skin Temperature Change
Délai: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.

Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor.

Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
When Patient Experiences First Pain
Délai: up to day 7 post operatively

Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history.

up to day 7 post operatively
Time of First Opioid Taken
Délai: Within the first 7 days after surgery

As measured by asking patients if they were taking opioids daily after surgery, up to one week.

Within the first 7 days after surgery
Total Post Operative MME/Opioid Usage at Day 1
Délai: On Post Operative Day 1

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 1
Total Post Operative MME/Opioid Usage at Day 2
Délai: On Post Operative Day 2

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 2
Total Post Operative MME Opioid Usage at Day 3
Délai: On Post Operative Day 3

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 3
Total Post Operative MME Opioid Usage at Day 4
Délai: On Post Operative Day 4

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 4
Total Post Operative MME Opioid Usage at Day 5
Délai: On Post Operative Day 5

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 5
Total Post Operative MME Opioid Usage at Day 6
Délai: On Post Operative Day 6

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 6
Opioid Usage Assessment at Day 7
Délai: On Post Operative Day 7

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 7
Opioid Usage Assessment at Day 28
Délai: On Post Operative Day 28

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day.

On Post Operative Day 28
Opioid Usage Assessment at 6 Months
Délai: On Post Operative Month 6

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day.

On Post Operative Month 6
Opioid Usage Assessment at 1 Year
Délai: On Post Operative 1 Year

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day.

On Post Operative 1 Year
Quality of Recovery
Délai: At Post Operative days 7 and 28 , 6 months, and 1 year

Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best.

PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being

PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed

At Post Operative days 7 and 28 , 6 months, and 1 year
General satisfaction
Délai: At post operative days 0, 1, 7, 28, 6 months, and 1 year

General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N).

At post operative days 0, 1, 7, 28, 6 months, and 1 year
Adverse Events
Délai: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.

Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness

Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
Catheter Duration Before Discontinuation
Délai: After surgery, up until catheter discontinuation.

Patients' catheter duration before discontinuation, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.
Total Local Anesthetic Use with Catheter
Délai: After surgery, up until catheter discontinuation.

Patients' local anesthetic use with catheter, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

23 juillet 2025

Achèvement primaire (Estimé)

30 juillet 2027

Achèvement de l'étude (Estimé)

30 juillet 2027

Dates d'inscription aux études

Première soumission

7 août 2024

Première soumission répondant aux critères de contrôle qualité

20 août 2024

Première publication (Réel)

22 août 2024

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

10 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Oui

produit fabriqué et exporté des États-Unis.

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner